Yang J, Zhou F, Luo X, Fang Y, Wang X, Liu X
Cell Death Discov. 2025; 11(1):84.
PMID: 40032852
PMC: 11876437.
DOI: 10.1038/s41420-025-02366-3.
Hamagami N, Kapadia D, Abduljawad N, Cheng Z, McLaughlin L, Singhania D
bioRxiv. 2025; .
PMID: 39975390
PMC: 11838276.
DOI: 10.1101/2025.01.30.635595.
Park B, Hua S, Casler K, Cefaloni E, Ayers M, Lake R
bioRxiv. 2025; .
PMID: 39974916
PMC: 11838576.
DOI: 10.1101/2025.02.03.636299.
Elmer D, Stockmaier G, Grund-Groschke S, Strobl V, Dang H, Wiederstein M
Cell Commun Signal. 2025; 23(1):91.
PMID: 39962447
PMC: 11834474.
DOI: 10.1186/s12964-025-02101-6.
Wang Y, Xiao K, Tao T, Zhang R, Shu H, Sun X
Int J Mol Sci. 2025; 26(3).
PMID: 39941033
PMC: 11818603.
DOI: 10.3390/ijms26031268.
Interferon-gamma rescues dendritic cell calcineurin-dependent responses to via Stat3 to Stat1 switching.
Adlakha A, Williams T, Shou X, Reed A, Lenhard B, Armstrong-James D
iScience. 2025; 28(2):111535.
PMID: 39898039
PMC: 11787545.
DOI: 10.1016/j.isci.2024.111535.
Epigene functional diversity: isoform usage, disordered domain content, and variable binding partners.
Bondhus L, Nava A, Liu I, Arboleda V
Epigenetics Chromatin. 2025; 18(1):8.
PMID: 39893491
PMC: 11786378.
DOI: 10.1186/s13072-025-00571-z.
The Histone Demethylase LSD1/ZNF217/CoREST Complex is a Major Restriction Factor of Epstein-Barr Virus Lytic Reactivation.
Liao Y, Gewurz B, Yan J, Kong I, Li Z, Ding W
Res Sq. 2025; .
PMID: 39877093
PMC: 11774438.
DOI: 10.21203/rs.3.rs-5649616/v1.
Inhibition of triglyceride metabolism-associated enhancers alters lipid deposition during adipocyte differentiation.
Zeng S, Li Z, Li X, Du Q, Zhang Y, Zhong Z
FASEB J. 2025; 39(2):e70347.
PMID: 39873971
PMC: 11774232.
DOI: 10.1096/fj.202401137R.
Multiscale footprints reveal the organization of cis-regulatory elements.
Hu Y, Horlbeck M, Zhang R, Ma S, Shrestha R, Kartha V
Nature. 2025; 638(8051):779-786.
PMID: 39843737
PMC: 11839466.
DOI: 10.1038/s41586-024-08443-4.
Super-enhancers in tumors: unraveling recent advances in their role in Oncogenesis and the emergence of targeted therapies.
Ji Y, Li B, Lin R, Yuan J, Han Y, Du Y
J Transl Med. 2025; 23(1):98.
PMID: 39838405
PMC: 11753147.
DOI: 10.1186/s12967-025-06098-x.
Skeletal muscle-specific Bambi deletion induces hypertrophy and oxidative switching coupling with adipocyte thermogenesis against metabolic disorders.
Yao X, Mai X, Tian Y, Liu Y, Jin G, Li Z
Sci China Life Sci. 2025; .
PMID: 39821828
DOI: 10.1007/s11427-023-2586-x.
LINE1 elements at distal junctions of rDNA repeats regulate nucleolar organization in human embryonic stem cells.
Ataei L, Zhang J, Monis S, Giemza K, Mittal K, Yang J
Genes Dev. 2025; 39(3-4):280-298.
PMID: 39797762
PMC: 11795452.
DOI: 10.1101/gad.351979.124.
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer.
Sui X, Cao S, Song X, Liu X, Chen C, Yan Q
Biomark Res. 2025; 13(1):6.
PMID: 39780291
PMC: 11715975.
DOI: 10.1186/s40364-024-00719-1.
MaizeCODE reveals bi-directionally expressed enhancers that harbor molecular signatures of maize domestication.
Cahn J, Regulski M, Lynn J, Ernst E, de Santis Alves C, Ramakrishnan S
Nat Commun. 2024; 15(1):10854.
PMID: 39738013
PMC: 11685423.
DOI: 10.1038/s41467-024-55195-w.
Epigenomic and 3D genomic mapping reveals developmental dynamics and subgenomic asymmetry of transcriptional regulatory architecture in allotetraploid cotton.
Huang X, Wang Y, Zhang S, Pei L, You J, Long Y
Nat Commun. 2024; 15(1):10721.
PMID: 39730363
PMC: 11680999.
DOI: 10.1038/s41467-024-55309-4.
Synthetic Promoters in Gene Therapy: Design Approaches, Features and Applications.
Artemyev V, Gubaeva A, Paremskaia A, Dzhioeva A, Deviatkin A, Feoktistova S
Cells. 2024; 13(23).
PMID: 39682712
PMC: 11640742.
DOI: 10.3390/cells13231963.
Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis.
Zhuang X, Wang Q, Joost S, Ferrena A, Humphreys D, Li Z
Nature. 2024; 637(8044):184-194.
PMID: 39633048
DOI: 10.1038/s41586-024-08285-0.
Regulatory mechanisms of steroid hormone receptors on gene transcription through chromatin interaction and enhancer reprogramming.
Sun G, Zhao C, Han J, Wu S, Chen Y, Yao J
Cell Oncol (Dordr). 2024; 47(6):2073-2090.
PMID: 39543064
DOI: 10.1007/s13402-024-01011-y.
Active enhancers: recent research advances and insights into disease.
Zhang J, Wang Q, Liu J, Duan Y, Liu Z, Zhang Z
Biol Direct. 2024; 19(1):112.
PMID: 39533395
PMC: 11556110.
DOI: 10.1186/s13062-024-00559-x.